Home › Steatotic Liver Disease › California › Rialto
Steatotic Liver Disease clinical trials in Rialto, CA
5 studies for Steatotic Liver Disease are looking for participants at sites in and around Rialto (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Rialto
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Rialto
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RecruitingPhase 2
- Inland Empire Clinical Trials, Rialto
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
RecruitingPhase 2
- GSK Investigational Site, Rialto
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
RecruitingPhase 1
- GSK Investigational Site, Rialto
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- New York City, NY16 studies
- Miami, FL16 studies
- San Diego, CA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Richmond, VA12 studies
- Tucson, AZ10 studies
- Chandler, AZ10 studies
- St. Louis, MO9 studies
- Orlando, FL9 studies
- Hialeah, FL9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.